SRP + rosuvastatin

SRP + rosuvastatin appears to refer to a combination of two agents, where "rosuvastatin" is a well-known statin (HMG-CoA reductase inhibitor) used for lowering LDL cholesterol and reducing cardiovascular risk[2][4]. The identity of "SRP" is unclear from available sources; it does not correspond to any widely recognized pharmaceutical agent, fixed-dose combination, or established abbreviation in the context of lipid-lowering therapy or cardiovascular medicine. Rosuvastatin works by inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL from the bloodstream[4]. If "SRP" refers to an investigational compound or a specific product not yet widely documented, no authoritative information is available as of May 2025.